New patent expiration for Biogen Idec drug SPINRAZA

Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier. There are nine patents…

The post New patent expiration for Biogen Idec drug SPINRAZA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.